Adrianna Gonzalez, MD
Dermatology · Washington, DCNPI 1326509746
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,086 of the $11,289 with a category attached, or 71.6%. 26 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 31.1% of the total.
Across 337 payments — averaging $33.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$4K
- AbbVie$1K
- Pfizer$798
- Johnson & Johnson$782
- Sanofi$774
- Lilly USA, LLC$560
- plus $4K from 20 others
What the payments were for
- Consulting fees$3,18028%
- Food & beverage$8,08672%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $3,509 |
| AbbVie | 54 | $1,197 |
| Pfizer | 23 | $798 |
| Johnson & Johnson(2 entities) | 10 | $782 |
| Sanofi | 25 | $774 |
| Lilly USA, LLC | 22 | $560 |
| UCB, Inc. | 25 | $507 |
| Incyte Corporation | 36 | $464 |
| E.r. Squibb & Sons, L.L.C. | 21 | $423 |
| Galderma Laboratories, L.p. | 21 | $355 |
| Novartis | 15 | $336 |
| Arcutis Biotherapeutics, Inc. | 11 | $328 |
| Sun Pharmaceutical Industries Inc. | 6 | $206 |
| Dermavant Sciences, Inc. | 12 | $206 |
| LEO Pharma Inc. | 4 | $174 |
| Amgen | 5 | $133 |
| Organon | 9 | $115 |
| Boehringer Ingelheim | 4 | $112 |
| Revance Therapeutics, Inc. | 4 | $110 |
| Journey Medical Corporation | 2 | $49 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Strata Skin Sciences, Inc. | 3 | $31 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Biofrontera Inc. | 1 | $19 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,289 in reported general payments places this provider in the 70th percentile of 73 dermatology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 25 | $2,453 |
| Ketoconazole | 12 | $186 |
| Triamcinolone Acetonide | 12 | $151 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Washington
- Jonathan SilverbergWashington$4.5M
- Adam FriedmanWashington$2.2M
- Terrence KeaneyWashington$1.1M
- Candrice HeathWashington$168K
- Agnes ChangWashington$109K
- Todd PerkinsWashington$102K
- Karl SaardiWashington$101K
- Noelle SherberWashington$96K
- Yolanda HolmesWashington$80K
- Cheri FreyWashington$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.